ARIAD PHARMACEUTICALS INC 4

4 · ARIAD PHARMACEUTICALS INC · Filed Nov 22, 2013

Form 4

Period: 2013-11-22

Senior VP, Chief Medical Off

Transactions

Exercise/Conversion
Common Stock
2013-11-22+9,000→ 82,282 total
Exercise/Conversion
Common Stock
2013-11-22+6,000→ 88,282 total
Exercise/Conversion
Restricted Stock Units
2013-11-22−6,000→ 6,000 total
Exp: 2022-03-20→ Common Stock (6,000 underlying)
Exercise/Conversion
Performance stock unit
2013-11-22−9,000→ 0 total
Exp: 2021-04-01→ Common Stock (9,000 underlying)
Exercise/Conversion
Common Stock
2013-11-22+6,000→ 73,282 total
Exercise/Conversion
Common Stock
2013-11-22+6,250→ 102,532 total
Exercise/Conversion
Restricted Stock Units
2013-11-22−6,250→ 12,500 total
Exp: 2023-03-19→ Common Stock (6,250 underlying)
Exercise/Conversion
Common Stock
2013-11-22+8,000→ 96,282 total
Exercise/Conversion
Restricted Stock Units
2013-11-22−6,000→ 0 total
Exp: 2021-04-01→ Common Stock (6,000 underlying)
Exercise/Conversion
Performance stock unit
2013-11-22−8,000→ 8,000 total
Exp: 2022-03-20→ Common Stock (8,000 underlying)

Holdings

Footnotes (2)

[F1]Each restricted stock unit or performance stock unit represents a right to receive one share of ARIAD common stock.
[F2]The vesting of these awards were accelerated to November 22, 2013, the reporting person's last day of employment with the Company, under the terms of his employment agreement.

Documents

1 file